The SRE Motif in the Human PNPLA3 Promoter (-97 to -88bp) Mediates Transactivational Effects of SREBP-1c

Journal of Cellular Physiology

Volumn 230, Issue 9, 2015, Pages 2224-2232

  Liang, Hua ^a   Xu, Jing ^a   Xu, Fen ^a   Liu, Hongxia ^a   Yuan, Ding ^a   Yuan, Shuhua ^a   Cai, Mengyin ^a   Yan, Jinhua ^a   Weng, Jianping ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CIS ACTING ELEMENT; INSULIN; NUCLEAR FACTOR Y; PATATIN LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3; PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; UNCLASSIFIED DRUG; ADIPONUTRIN, HUMAN; CCAAT BINDING FACTOR; MEMBRANE PROTEIN; PROTEIN BINDING; SREBF1 PROTEIN, HUMAN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL LIPASE;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; DNA BINDING; DNA FLANKING REGION; DOSE; FUSION GENE; GEL MOBILITY SHIFT ASSAY; GENE IDENTIFICATION; GENE MUTATION; GENE OVEREXPRESSION; HEPG2 CELL LINE; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; MALE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN MOTIF; RAT; TRANSACTIVATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TRANSIENT TRANSFECTION; WESTERN BLOTTING; WILD TYPE; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; LIVER; METABOLISM; MUTATION; NONALCOHOLIC FATTY LIVER; PATHOLOGY;

CCAAT-BINDING FACTOR; GENE EXPRESSION REGULATION; HEP G2 CELLS; HUMANS; INSULIN; LIPASE; LIVER; MEMBRANE PROTEINS; MUTATION; NON-ALCOHOLIC FATTY LIVER DISEASE; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTIONAL ACTIVATION;

EID: 84929832617     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24951     Document Type: Article

References (34)

1. Baulande S, Lasnier F, Lucas M, Pairault J. 2001. Adiponutrin, a transmembrane protein corresponding to a novel dietary- and obesity-linked mRNA specifically expressed in the adipose lineage. J Biol Chem 276:33336-33344.
2. Dooley KA, Millinder S, Osborne TF. 1998. Sterol regulation of 3-hydroxy-3-methylglutaryl-coenzyme A synthase gene through a direct interaction between sterol regulatory element binding protein and the trimeric CCAAT-binding factor/nuclear factor Y. J Biol Chem 273:1349-1356.
3. Dubuquoy C, Robichon C, Lasnier F, Langlois C, Dugail I, Foufelle F, Girard J, Burnol AF, Postic C, Moldes M. 2011. Distinct regulation of adiponutrin/PNPLA3 gene expression by the transcription factors ChREBP and SREBP1c in mouse and human hepatocytes. J. Hepatol 55:145-153.
4. Eberle D, Hegarty B, Bossard P, Ferre P, Foufelle F. 2004. SREBP transcription factors: Master regulators of lipid homeostasis. Biochimie 86:839-848.
5. Faraj M, Beauregard G, Loizon E, Moldes M, Clement K, Tahiri Y, Cianflone K, Vidal H, Rabasa-Lhoret R. 2006. Insulin regulation of gene expression and concentrations of white adipose tissue-derived proteins in vivo in healthy men: Relation to adiponutrin. J Endocrinol 191:427-435.
6. Foretz M, Guichard C, Ferre P, Foufelle F. 1999. Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci USA 96:12737-12742.
7. Horton JD, Goldstein JL, Brown MS. 2002. SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109:1125-1131.
8. Huang Y, He S, Li JZ, Seo YK, Osborne TF, Cohen JC, Hobbs HH. 2010. A feed-forward loop amplifies nutritional regulation of PNPLA3. Proc Natl Acad Sci USA 107:7892-7897.
9. Jackson SM, Ericsson J, Mantovani R, Edwards PA. 1998. Synergistic activation of transcription by nuclear factor Y and sterol regulatory element binding protein. J Lipid Res 39:767-776.
10. Johansson LE, Hoffstedt J, Parikh H, Carlsson E, Wabitsch M, Bondeson AG, Hedenbro J, Tornqvist H, Groop L, Ridderstråle M. 2006. Variation in the adiponutrin gene influences its expression and associates with obesity. Diabetes 55:826-833.
11. Kawaguchi T, Sumida Y, Umemura A, Matsuo K, Takahashi M, Takamura T, Yasui K, Saibara T, Hashimoto E, Kawanaka M, Watanabe S, Kawata S, Imai Y, Kokubo M, Shima T, Park H, Tanaka H, Tajima K, Yamada R, Matsuda F, Takeshi Okanoue Japan Study Group of Nonalcoholic Fatty Liver Disease. 2012. Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese. PLoS ONE 7:e38322.
12. Kershaw EE, Hamm JK, Verhagen LA, Peroni O, Katic M, Flier JS. 2006. Adipose triglyceride lipase: Function, regulation by insulin, and comparison with adiponutrin. Diabetes 55:148-157.
13. Kotronen A, Johansson LE, Johansson LM, Roos C, Westerbacka J, Hamsten A, Bergholm R, Arkkila P, Arola J, Kiviluoto T, Fisher RM, Ehrenborg E, Orho-Melander M, Ridderstråle M, Groop L, Yki-Järvinen H. 2009. A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans. Diabetologia 52:1056-1060.
14. Kumari M, Schoiswohl G, Chitraju C, Paar M, Cornaciu I, Rangrez AY, Wongsiriroj N, Nagy HM, Ivanova PT, Scott SA, Knittelfelder O, Rechberger GN, Birner-Gruenberger R, Eder S, Brown HA, Haemmerle G, Oberer M, Lass A, Kershaw EE, Zimmermann R, Zechner R. 2012. Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase. Cell Metab 15:691-702.
15. Lake AC, Sun Y, Li JL, Kim JE, Johnson JW, Li D, Revett T, Shih HH, Liu W, Paulsen JE, Gimeno RE. 2005. Expression, regulation, and triglyceride hydrolase activity of adiponutrin family members. J Lipid Res 46:2477-2487.
16. Li JZ, Huang Y, Karaman R, Ivanova PT, Brown HA, Roddy T, Castro-Perez J, Cohen JC, Hobbs HH. 2012. Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis. J Clin Invest 122:4130-4144.
17. Li Y, Xing C, Cohen JC, Hobbs HH. 2012. Genetic variant in PNPLA3 is associated with nonalcoholic fatty liver disease in China. Hepatology 55:327-328.
18. Liu YM, Moldes M, Bastard JP, Bruckert E, Viguerie N, Hainque B, Basdevant A, Langin D, Pairault J, Clément K. 2004. Adiponutrin: A new gene regulated by energy balance in human adipose tissue. J Clin Endocrinol Metab 89:2684-2689.
19. Mantovani R. 1999. The molecular biology of the CCAAT-binding factor NF-Y. Gene 239:15-27.
20. Meli R, Mattace Raso G, Irace C, Simeoli R, Di Pascale A, Paciello O, Pagano TB, Calignano A, Colonna A, Santamaria R. 2013. High fat diet induces liver steatosis and early dysregulation of iron metabolism in rats. PLoS ONE 8:e66570.
21. Moldes M, Beauregard G, Faraj M, Peretti N, Ducluzeau PH, Laville M, Rabasa-Lhoret R, Vidal H, Clément K. 2006. Adiponutrin gene is regulated by insulin and glucose in human adipose tissue. Eur J Endocrinol 155:461-468.
22. Perttila J, Huaman-Samanez C, Caron S, Tanhuanpaa K, Staels B, Yki-Jarvinen H, Olkkonen VM. 2012. PNPLA3 is regulated by glucose in human hepatocytes, and its I148M mutant slows down triglyceride hydrolysis. Am J Physiol Endocrinol Metab 302:E1063-E1069.
23. Petit JM, Guiu B, Masson D, Duvillard L, Jooste V, Buffier P, Bouillet B, Brindisi MC, Robin I, Gambert P, Verges B, Cercueil JP, Hillon P. 2011. PNPLA3 polymorphism influences liver fibrosis in unselected patients with type 2 diabetes. Liver Int 31:1332-1336.
24. Qiao A, Liang J, Ke Y, Li C, Cui Y, Shen L, Zhang H, Cui A, Liu X, Liu C, Chen Y, Zhu Y, Guan Y, Fang F, Chang Y. 2011. Mouse patatin-like phospholipase domain-containing 3 influences systemic lipid and glucose homeostasis. Hepatology 54:509-521.
25. Rae-Whitcomb SM, Kennedy D, Voyles M, Thompson MP. 2010. Regulation of the promoter region of the human adiponutrin/PNPLA3 gene by glucose and insulin. Biochem Biophys Res Commun 402:767-772.
26. Rampal S, Basu RC, Mohamed Z. 2012. A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease. Hum Genet 131:1145-1152.
27. Reed BD, Charos AE, Szekely AM, Weissman SM, Snyder M. 2008. Genome-wide occupancy of SREBP1 and its partners NFY and SP1 reveals novel functional roles and combinatorial regulation of distinct classes of genes. PLoS Genet 4:e100013.
28. Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, Boerwinkle E, Cohen JC, Hobbs HH. 2008. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 40:1461-1465.
29. Singal AG, Manjunath H, Yopp AC, Beg MS, Marrero JA, Gopal P, Waljee AK. 2014. The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: A meta-analysis. Am J Gastroenterol, 109:325-334.
30. Sookoian S, Pirola CJ. 2011. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology 53:1883-1894.
31. Sookoian S, Castano GO, Burgueno AL, Gianotti TF, Rosselli MS, Pirola CJ. 2009. A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity. J Lipid Res 50:2111-2116.
32. Tian C, Stokowski RP, Kershenobich D, Ballinger DG, Hinds DA. 2010. Variant in PNPLA3 is associated with alcoholic liver disease. Nat Genet 42:21-23.
33. Trépo E, Nahon P, Bontempi G, Valenti L, Falleti E, Nischalke HD, Hamza S, Corradini SG, Burza MA, Guyot E, Donati B, Spengler U, Hillon P, Toniutto P, Henrion J, Franchimont D, Devière J, Mathurin P, Moreno C, Romeo S, Deltenre P. 2013. Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data. Hepatology, 59:2170-2177.
34. Wilson PA, Gardner SD, Lambie NM, Commans SA, Crowther DJ. 2006. Characterization of the human patatin-like phospholipase family. J Lipid Res 47:1940-1949.